BridgeMD
New treatment option for Non-Small Cell Lung Cancer (NSCLC)
Official title Digital Lifestyle Intervention for Lung Cancer Survivors
ClinicalTrials.gov ID: NCT05819346
What this study is testing
- What it's testing
- The aim of this study is to assess the efficacy of a digital lifestyle intervention in non-small cell lung cancer (NSCLC) survivors on health-related quality of life (HRQoL) over three months.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Age ≥ 18 years
- Diagnosis of non-small cell lung cancer (NSCLC)
- Estimated life expectancy of ≥ six months (judged by local investigators/responsible health professionals)
- Undergoing inpatient or outpatient rehabilitation OR completion of planned surgery, chemotherapy, or radiation therapy for NSCLC within the past 24...
- Knowledge of German to understand study material and assessments
You likely can't join if
- Inability to provide informed consent
- Inability to participate in the intervention because of physical, cognitive, or safety reasons (judged by local investigators/responsible health...
See the full eligibility criteria
- Age ≥ 18 years
- Diagnosis of non-small cell lung cancer (NSCLC)
- Estimated life expectancy of ≥ six months (judged by local investigators/responsible health professionals)
- Undergoing inpatient or outpatient rehabilitation OR completion of planned surgery, chemotherapy, or radiation therapy for NSCLC within the past 24 weeks
- Knowledge of German to understand study material and assessments
- Access to a cell phone or tablet
- Written informed consent
- Inability to provide informed consent
- Inability to participate in the intervention because of physical, cognitive, or safety reasons (judged by local investigators/responsible health professionals)
The study team makes the final eligibility decision.
Where it's taking place
- Barmelweid, Switzerland
- Davos, Switzerland
- Heiligenschwendi, Switzerland
- Wald, Switzerland
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Barmelweid, Switzerland; Davos, Switzerland; Heiligenschwendi, Switzerland; Wald, Switzerland. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.